Regional cerebral blood flow was studied by means of the U3 Xe inhalation method hi 26 untreated and 10 treated patients with essential hypertension. The untreated subjects were divided into newly and previously diagnosed groups to assess the relation between regional cerebral blood flow and the duration of hypertension. The overall flow reduction was more marked in the frontal and temporal regions hi the previously diagnosed group, and this was attributed to pathological changes in the district served by the middle cerebral artery. Regional temporal lobe impairment was also noted in the newly diagnosed and treated subjects. A significant correlation was found between regional cerebral blood flow and mean arterial blood pressure. (Stroke 1987; 18:13-20) 
H
YPERTENSION is the primary prelude to stroke and other cerebrovascular diseases. Its status as a risk factor is apparent in several randomized and controlled epidemiological studies indicating a high correlation between blood pressure and the incidence of stroke. There is evidence, too, that proper drug management is effective in reducing the risk of cerebrovascular accidents, even in mild hypertensives.
1 "4 Furthermore, though clear proof is not yet available, there is reason to suppose that the declining incidence of stroke in recent years is ascribable to extensive educational programs and the precise detection and therapy of hypertension. 5 " 7 Given this close relation between hypertension and cerebrovascular disease, the cerebral blood flow (CBF) is naturally a key parameter. While CBF changes have been demonstrated in chronic hypertension, 8 " 12 no specific data are available for mild or moderate forms or for during the initial stages of the disease. This study reports a l33 Xe inhalation assessment 1314 of regional cerebral blood flow (rCBF) in patients with treated and untreated mild or moderate hypertension. The untreated subjects were divided into "newly" and "previously" diagnosed groups to look for a relation between CBF and the duration of hypertension. An age-matched population served as the control. A computer system providing a two-dimensional color mapping display devised in our laboratory 13 was used in the statistical processing to provide a visual indication of the rCBF.
Subjects and Methods
Patients with hypertension were selected from 162 subjects to form untreated (26 patients) and treated (10 patients) groups.
UNTREATED GROUP. 1) Mild (diastolic pressure 9 0 -104 mm Hg) or moderate (diastolic pressure 105-114 mm Hg) hypertension according to Freis 16 as shown by conventional diagnostic assessment 17 ; 2) no history of significant disorders, asymptomatic and normal neurological and general pictures, obese patients (more than 120% of ideal body weight) excluded; 3) normal serum cholesterol, triglycerides, glucose, and total proteins, normal hematocrit and platelet count; 4) no current treatment of any kind and no history of antihypertensive management.
A further distinction was drawn between patients diagnosed for the first time by us (newly diagnosed; Group 1: 6 men and 7 women aged 50-74 years, mean = 62.84 ± 6.78; mean arterial blood pressure [MABP] = 121.0 ± 5.19 mm Hg; Table 1 ) and those diagnosed at least 6 months previously (previously diagnosed; Group 2: 8 men and 5 women aged 50-72 years, mean = 61.30 ± 6.63; MABP = 122.90 ± 6.70 mm Hg; duration of hypertension 0.5-4 years, mean = 1.34 ± 1.10; Table 2 ).
TREATED GROUP. Group 3: 5 men and 5 women aged 50-72 years, mean = 63.10 ± 7.03, meeting criteria 1-3 of the untreated group; MABP = 112.30 ± 6.17; known duration of hypertension 0.5-20 years, mean = 8.15 ± 7.62; Table 3 ). These patients had been treated with various drugs since their hypertension was discovered.
The fundus oculi was examined in all patients in Groups 1, 2, and 3 (Tables 1-3 ). The Keith-Wagener classification was used in the assessment of retinopathy. The controls were healthy volunteers: 11 men and 15 women aged 48-80 years, mean = 62.05 ± 9.10; MABP = 97.65 ± 5.64.
Informed consent was received from all subjects. All rCBF examinations were performed under the same laboratory conditions. rCBF at rest was measured by the 133 Xe inhalation method, using a Harshaw TASC 5 system with 32 detectors (16 on each hemisphere). Expired end-tidal Pco 2 was monitored using a Goddard Mark II capnograph.
The airl33 Xe mixture was administered through a facemask at 6-7 mCi/1 in the first minute. The patient then received room air for 10 minutes. The washout curves were subjected to a two-compartment analysis 14 using a Digital PDP 11/04 computer. For the purpose of this report only the initial slope index (ISI) was considered, since it is regarded as the most indicative of cerebral pathology. 18 ISI values were not corrected for individual Pco 2 levels. 19 All subjects were normocapnic: Mean end-tidal Pco 2 values in Group 1 were 39.9 ± 3.2; in Group 2, 38.7 ± 3.9; in Group 3, 39.2 ± 4.2; in controls, 38.6 ± 3.3.
For statistical purposes, the mean ISI value of each probe (mean single probe values = MSPV's), of all probes in both hemispheres (mean global values = MGV's), and in each hemisphere (mean hemispheric values = MHV's) were calculated. Using the unpaired t test, MSPV's, MHV's, and MGV's were compared between each patient group and the controls, and among the groups of patients.
In untreated patients (Group 1 + Group 2), the MGV's were regressed against the duration of hypertension and age respectively; in the controls, MGV's were regressed against age. MABP's were correlated with MGV's in all subjects regarded as a single population. Analysis of variance (ANOVA) was used to evaluate interhemispherical differences in each group.
An additional statistical evaluation of rCBF was obtained with an original computer-assisted system developed in our laboratory. 15 Briefly, a) the skull locations of and relative distances between the 32 probes were shown on a 64 x 64 matrix. The matrix within each hemisphere was formed into triangular patches by lines joining triplets of nearby probes ( Figure 1) ; b) the flow value for each probe was ascribed to the corresponding vertex of each triangle. The numerical values of the pixels inside each triangle were interpolated from the values at the vertices; c) a relation was established between a 12-grade green-to-red color scale and raw numerical data; d) simultaneous presentation of the interpolated colored triangular patches on a monitor gave a bidimensional map of flow values over the whole brain surface; e) the mean flow value maps of two different populations were automatically compared using the unpaired t test. The graphic output of the comparison was a topographic distribution of the statistical probability of the differences displayed as a 6-level pseudocolor scale. Data processing to obtain the color maps was performed on a Digital PDP 11/23 Plus connected to an image processing system (VDS 701).
Results

Mean Global Values (MGVs)
1. ISI values: The MGV of each subject and the group means ± SD are presented in Figure 2 . In Table  4 , the results of the comparisons are reported. MGV's were significantly reduced (p < 0.01) in Group 2 and in all untreated cases compared with the controls. No other significant differences were found.
2. Correlations between MGV's and age: No significant correlation was found between MGV's and age in all untreated patients (r = -0.29), nor in the controls (r = -0.09).
3. Correlations between MGV's and duration of 
Abbreviations as in Table 2 .
hypertension: A significant correlation was found in all untreated patients (r = -0.48; p < 0.02). 
Mean Hemispheric Values (MHVs)
The comparisons between each group of patients and the controls are reported in Table 4 . Group 1 showed only a slightly significant reduction in the left (p < 0.02) and right (p < 0.05) hemispheres; Group 2 showed the greatest reduction in both hemispheres (p < 0.001). No other comparison was significant.
Mean Single Probe Values (MSPV's)
The MSPV's and significant differences are reported in Table 5 . Group 1 presented significantly reduced ISI only in probes 13, 14, and 16 in the right and probes 27, 29-32 in the left hemisphere. Group 2 had reduced ISI values in all probes. Group 3 showed a 
FIGURE 2. Mean global ISI values (MGV s) and means ± SD: Controls (n = 26); newly diagnosed hypertensives (Group 1, n = 13); previously diagnosed hypertensives (Group 2, n = 13); and treated hypertensives (Group 3, n = 10).
Controls
Newly diagnosed Previously Treated hypertensives diagnoses hypertensives hypertenswes significant reduction of ISI values only in probes 27, 29-31 in the left hemisphere.
ANOVA failed to show significant interhemispheric differences.
Bidimensional Maps
The map of the statistical comparison between controls (CNTRLS) and Group 1 (NDHT) demonstrated a flow decrease in the temporal regions only (Figure 4 
Discussion
Mean Global Values and Mean Hemispheric Values
There was a significant reduction in overall CBF, particularly in the previously diagnosed group, Group 2. This may be ascribable to vascular hypertrophy, 20 -21 which is the main anatomical change observed in cere- 
MABP
bral vessels in hypertension and which increases the wall: lumen ratio. Hypertrophy was primarily found in medium-sized and small vessels in an autopsy study of 100 chronic hypertensive patients, with only minor involvement of the larger arteries. 22 Other workers have found that even the capillaries may be affected. 23 It may be presumed that these arteriosclerotic changes protect both the vessels and the brain from the effects of hypertension. On the other hand, arteriosclerosis alters the supply of oxygen and other nutrients to the neurons. Since CBF is linked to the brain metabolic rate, 24 it may thus be assumed that hypertrophy results in an overall fall in CBF, as was apparent in our untreated subjects. There is other evidence along these lines. Terashi has shown that hypertension plus arteriosclerosis decreases both CBF and brain metabolism. 12 Thickening of the arterial wall in the terminal stage of severe hypertension was responsible for a severe and irreversible decrease in rCBF in Yamori and Horie's stroke-prone spontaneously hypertensive rats. 8 Moreover, hypertension, along with hyperlipemia, smoking, and diabetes, is a well-known risk factor for atherosclerosis. Our study did not take smoking habits into account. The other risk factors, however, were excluded. Atherosclerosis was not clinically evident and other examinations (e.g., angiography) to detect it were not undertaken. If present, it could have contributed to reduced CBF in the untreated group. The conclusion to be drawn is that these findings, which are partly coincident with those of Naritomi et al 23 and Shaw et al," could reflect a combination of hypertension and atherosclerosis.
The treated group was comparable with the controls. Antihypertensive management increased CBF in direct proportion to the reduction of blood pressure in Yamori and Horie's rats. 8 No inference can be drawn with regard to management's efficacy from our small series of poorly homogeneous patients in Group 3 (different drugs and blood pressure, blood pressure at time of diagnosis unknown, different hypertension duration and length of treatment). Even so, it would seem that antihypertensive therapy may alter the natural course of the disease as far as CBF is concerned. Meyer et al, for example, observed a significant increase in CBF in treated as opposed to untreated patients one month after a stroke. 26 That reduction of CBF is the result of hypertension as opposed to normal aging is made strikingly clear by the significant negative linear correlation between MABP and ISI, whereas no correlation could be found between ISI and age.
The relation between MGV's and duration of hypertension is not clear. One study shows that hypertension causes a temporary decrease in CBF, whereas longstanding hypertension results in arteriosclerosis followed by a depressed CBF. 9 Tazaki found high and low CBF in hypertensives under 50 and over 50 re- spectively, suggesting that aging plus chronic hypertension results in cerebrovascular changes leading to a reduction in CBF. 10 The slightly significant correlation between MGV's and the duration of hypertension in our untreated subjects can be seen as an expression of gradual CBF impairment over time. The stages of this process, of course, cannot be deduced from our data.
Mean Single Probe Values
Regional CBF decreases in the untreated group were indicative of a pathological process spreading from the temporal areas to the whole brain, especially to the districts served by the middle cerebral artery. Our results are in line with those of Naritomi et al diagnosed patients displayed a marked reduction in the left temporal area. This was also true, though to a lesser degree, in the treated group. It may be that this area is especially prone to vascular damage, even though no significant difference between the hemispheres was detected. Summing up: A reduction in ISI values was observed in mild-moderate untreated hypertensives, whereas patients whose blood pressure had been lowered by therapy displayed only slight left temporal rCBF impairment.
